Sichenzia Ross Ference Kesner LLP

Author Archives: Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $3.8 Million Private Placement

moneyonmobile logo

Press Release – New York, NY – March 10, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors where MOMT sold an aggregate of 6,328,610 shares of Common Stock and five-year warrants to purchase 1,265,725 shares of Common Stock at an exercise price equal to $1.00 per share. MOMT received approximately $3.8M in gross proceeds from the offering.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Marathon Patent Group, Inc. in $2.66 Million Registered Direct Offering.

marathon patent group

Press Release – New York, NY – April 24, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Marathon Patent Group, Inc. (Nasdaq: Mara), an IP licensing and commercialization company, in a registered direct public offering of 3,800,000 registered shares of its common stock and 2,280,000 warrants at a price of $0.70 per share for gross proceeds of approximately $2,660,000.
continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for $2.1 Million Private Placement

protea biosciences

Press Release – New York, NY – April 17, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that between November 2016 and March 2017 it represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Protea Biosciences Group, Inc. (OTCQB: PRGB), a molecular information company that has developed a technology which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.

continue reading >>

Ronen Kantor

ronen kantor - Securities Law Firm | Sichenzia Ross Ference Kesner LLP

Managing Partner at DTKGC-SRFK*

Introduction

Ronen Kantor, Adv. is the founder of Kantor and Co. - Law offices and a managing partner of DTKGC . Mr. Kantor heads all the Corporate Finance Activities at DTKGC and is involved in most of the corporate transactions being managed by the firm. Mr. Kantor founded Kantor & co. Law Offices in 2000 with the goal of serving an increasing number of Israeli and foreign clients in various Corporate Finance activities both in Israel and internationally.

Mr. Kantor counsels public and private companies in securities matters in Israel, the US and the UK, and also in complex Merger and Acquisition transactions. Mr. Kantor's primary focus is corporate finance and securities laws, biotechnology and biopharmaceutical transactions, venture capital investments, private equity financings, mergers and acquisitions, general corporate law and other related activities.


*Ronen Kantor is a member of DTKGC-SRFK. This website is the website of the law firm Sichenzia Ross Ference Kesner LLP, a limited liability partnership doing business in New York and New Jersey. Services in Israel are provided through SRFK-DTKGC, a law firm organized under the laws of Israel that conducts business in Ramat Gan and Haifa in Israel. Sichenzia Ross Ference Kesner LLP and DTKGC-SRFK are each separate and independently owned firms. The Firms are parties to an affiliation agreement and operate under the global brands “Sichenzia Ross Ference Kesner LLP”, “SRFK LLP” and “DTKGC-SRFK”.

Professionals | Ronen Kantor | Sichenzia Ross Friedman Ference LLP

Education

University of Sheffield, England (LL.E. Honors, 1993)

Bar Admissions

Israeli Bar Association

Practice Areas

Corporate Law Group

Israeli Securities Law Group

Securities Law Group (U.S. and UK)

Israel practice group

Mergers and Acquisitions

Venture Capital & Investments

Private Equity Financings

Biotechnology & Licensing

International Transactions​

Contact Address

Office: Ramat Gan, Israel 5250606

Phone: +972-3-6133371

Fax: +972-3-6133372

Email: rkantor@dtkgc.com

Download vCard

Jeffrey R. Burke

Jeffrey R. Burke - Securities Law Firm | Sichenzia Ross Ference Kesner LLP

Partner

Introduction

Mr. Burke is an experienced litigator, regulatory enforcement, and financial services attorney who has successfully represented and advised major domestic and foreign companies and prominent executives in a broad range of high stakes litigations, business and employment disputes, regulatory investigations and compliance issues.

His practice focuses on representing issuers, underwriters, broker-dealers, hedge funds, private equity funds, officers, directors, and other executives in securities fraud litigation, shareholder derivative actions, regulatory investigations and internal investigations. Mr. Burke has extensive experience in federal and state court, before the United States Securities and Exchange Commission, Financial Industry Regulatory Authority (FINRA), and state regulatory bodies and in multiple arbitration forums.

Mr. Burke also advises financial services companies in connection with compliance related issues arising under the federal securities laws, FINRA rules and regulations and state securities requirements.

Experience

Prior to joining Sichenzia, Ross, Ferrence Kesner LLP, Mr. Burke was a partner in the securities litigation and regulatory enforcement group of a major international law firm. Prior to his 13 years at the law firm, Mr. Burke worked in a regulatory and compliance capacity in the financial services industry, including at the Division of Enforcement of the New York Stock Exchange, Inc. (K/N/A FINRA).

Education

Brooklyn Law School, J.D.

Marist College, B. A. Economics

Bar Admissions


State of New York; United States District Courts, Eastern and Southern Districts of New York and United States Courts of Appeal, Second Circuit

Practice Areas

Broker dealer regulation

Business litigation & arbitration

Contact Address

Office: New York

Phone: (212)-930-9700

Fax: (212)-930-9725

Email: jburke@srfkllp.com

Download vCard

Evan A. Berger

evan berger

Associate

Introduction

Evan A. Berger is an associate in the firm’s Corporate and Securities practice group. Mr. Berger represents public and privately-held companies in a wide range of corporate transactions.

Education

Mr. Berger received a J.D. from Fordham University School of Law where he was an associate editor for the Fordham Urban Law Journal and a member of the Brendan Moore Trial Advocacy Center. Mr. Berger received a B.A. from the University of Michigan.

evan berger

Education

J.D., Fordham University School of Law

B.A., University of Michigan

Bar Admissions

Mr. Berger is admitted to practice in New York and New Jersey

Practice Areas

Corporate law group

Securities law group

Contact Address

Office: New York

Phone: (212)-930-9700

Fax: (212)-930-9725

Email: eberger@srfkllp.com

Download vCard

Robert Volynsky

Associate

Introduction

Robert Volynsky is an associate in the firm’s Litigation Department. Mr. Volynsky engages in securities and general commercial litigation in both state and federal courts and before regulatory agencies, including the Securities and Exchange Commission and the Financial Industry Regulatory Authority. Prior to joining the firm, Mr. Volynsky interned as an Enforcement Intern in the Real Estate Finance Bureau at the New York State Attorney General’s office.

Education

Hofstra University School of Law, J. D. Honors Concentration in Business Law; Vice President, Dispute Resolution Society

University of California, Los Angeles, B.A.​

Bar Admissions

Robert is admitted to practice in California, New York, and New Jersey.

Practice Areas

Business Litigation & Arbitration

Contact Address

Office: New York

Phone: (212)-930-9700

Fax: (212)-930-9725

Email: rvolynsky@srfkllp.com

Download vCard

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down

tonix pharmaceuticals

Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Investor in a Private Placement of up to $5,000,000 in Series B Preferred Stock of Digital Power Corporation

Press Release – New York, NY – March 29, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Philou Ventures, LLC (“Philou”) in connection with its entry into a Preferred Stock Purchase Agreement (the “Purchase Agreement”) with Digital Power Corporation, a California corporation (the “Company”), a solution-driven organization that designs, develops, manufactures and sells high-grade customized and flexible power system solutions for applications in the medical, military, telecom and industrial markets.  The Purchase Agreement was executed on March 9, 2017.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Featured in Article Discussing Uptick in Coal and Gas IPOs

Press Release – New York, NY– March 28, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Law360 about the return of coal and gas issuers to the initial public offering landscape after a long absence. Greg attributed the boost partly to a change in administration, as investors expect a friendlier regulatory environment under the Trump administration. The article, titled “Coal Cos. Are Forging A Return To The IPO Pipeline,” is available here.

Sichenzia Ross Ference Kesner LLP Advises Laidlaw & Co. (UK) Ltd. on U.S. Public Offering and NASDAQ Listing of Israeli Cannabinoid Research Company Therapix Biosciences, Ltd. (TRPX)

therapix biosciences logo

Press Release – March 27, 2017 – New York, NY – Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the successful completion of a U.S. underwritten public offering of American Depositary Shares by Therapix Biosciences Ltd. (“Therapix”) an Israeli public company.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd., in a $2.8 Million Private Placement of ADSs.

xtlbio logo

Press Release – New York, NY – March 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals Ltd.  (“XTLB. NASDAQ”), an Israeli biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of lupus and other autoimmune diseases, in a private placement offering with existing investors where XTLB issued 1,400,000 American Depository Shares (ADSs) at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.

innovus pharma

Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $3.5 Million Public Offering

pareteum logo

Press Release – New York, NY – March 20, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSEMKT: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in an underwritten public offering of 2,333,334 shares of common stock at a public offering price of $1.50 per share together with the issuance of 1,166,667 five year warrants to purchase common stock with an exercise price of $1.87.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Discusses Shareholder Comments that Impact Stock Price

Press Release – New York, NY– March 13, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Business Insider about comments on Pandora stock by Liberty Media CEO Greg Maffei.  The article, titled “This media mogul has wreaked havoc on Pandora’s stock price for months — and he’s not slowing down,” discusses recent positive and negative comments by Mr. Maffei about Pandora. Greg addressed the legality of public statements that can impact stock price. 

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.

Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Featured in CNBC Story on Investing in Start-ups

Press Release – New York, NY – March 3, 2017 – Founding Partner Gregory Sichenzia was recently featured in a CNBC article authored by Kayleigh Kulp. The article entitled, “New Horizons: How to Invest in a Startup,” reviews the many things investors must know to effectively evaluate and invest in a start up.

continue reading >>

ROTH

Sichenzia Ross Ference Kesner LLP is a silver sponsor of the 29th Annual ROTH Conference, to be held at the Ritz Carlton in Dana Point, CA on March 12th – March 15th, 2017. The ROTH Conference, with close to 500 participating companies and over 4,000 attendees, will feature presentations from hundreds of public and private companies. The event will focus on healthcare, technology, internet & media, cleantech, industrial growth & solar, consumer, oil & gas, mining & minerals and business services.

March 12 – 15, 2017
Dana Point, CA

The Ritz Carlton
1 Ritz Carlton Dr
Dana Point, CA 9262

Learn More…

Pioneers 2017 Presented By Joseph Gunnar & Co., LLC

Sichenzia Ross Ference Kesner LLP is a sponsor of the Pioneers 2017 Conference presented by Joseph Gunnar & Co., LLC, to be held at the Mandarin Oriental in New York, NY on May 2nd, 2017. The conference will feature company presentations, one-on-one investor meetings and networking opportunities, with a focus on defense, tech and healthcare companies. Many members of Sichenzia Ross Ference Kesner LLP will be attending this event.

May 2nd, 2017
New York, NY

Mandarin Oriental
80 Columbus Circle,
New York, NY 10023

Learn More.

Oppenheimer’s 17th Annual Israeli Conference

Representatives of Sichenzia Ross Ference Kesner LLP and our affiliates, Doron, Tikotzky, Kantor, Gutman, Cederboum and Co., will be attending Oppenheimer’s 17th Annual Israel Conference, to be held at the David Intercontinental Hotel in Tel-Aviv on Sunday, May 21st 2017. Guests will include insurance companies, pension funds, provident funds, mutual funds, banks, venture capitals, and money managers. Based on previous years’ events, this conference is expected to attract approximately 500 participants, more than 40 Israeli companies, as well as considerable media coverage.

May 21st, 2017
Tel-Aviv, Israel

David Intercontinental Hotel
Kaufmann St 12, Tel Aviv-Yafo, 61501, Israel

Learn More

Mixiii BioMed 2017 Conference

Representatives of Sichenzia Ross Ference Kesner LLP and our affiliates, Doron, Tikotzky, Kantor, Gutman, Cederboum and Co., will be attending Biomed’s 16th National Life Science & Technology Conference, to be held at the David Intercontinental in Tel-Aviv, Israel on May 23rd – May 25th, 2017. Biomed has positioned itself throughout the years as the main annual meeting place for players of Israel’s healthcare industry with their colleagues from around the globe. It presents a unique and exuberating occasion for participating in discussions, panel presentations, product demonstrations and networking opportunities, all paving the way for new business collaborations.

May 23rd – May 25th, 2017
Tel-Aviv, Israel

David Intercontinental Hotel
Kaufmann St 12, Tel Aviv-Yafo, 61501, Israel

Learn More.

Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. in $4.8 Million Public Offering

functionx logo

Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. as joint book-running managers in the underwritten public offering of common stock of Function(x) Inc. (NASDAQ: FNCX).  Function(x) operates Wetpaint.com and Rant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management as Warrant Agent in $2.3 Million Warrant Exchange and Exercise for AYTU BioScience, Inc.

aytu bioscience

Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC and Fordham Financial Management, Inc. as warrant solicitation agents in a $2.3 warrant exchange and exercise for Aytu Bioscience, Inc. (OTCQB “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in $4.15 Million Private Placement and Debt Conversion

medovex corporation

Press Release – New York, NY – March 1, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a private placement of units consisting of 3,071,634 shares of common stock and 1,535,817 warrants to purchase common stock at a fixed price of $1.04 per unit resulting in gross proceeds of $3,022,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd. in $2.5 Million Registered Direct Offering

xtlbio logo

Press Release – New York, NY – February 27, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals, Ltd. (NASDAQ: XTLB) (TASE: XTL.TA), an Israeli clinical-stage biopharmaceutical company developing treatments for autoimmune diseases, in a registered direct offering of 1,000,000 American Depository Shares (“ADSs”) at a price of $2.50 per share and unregistered warrants to purchase 1,000,000 ADSs at an exercise price of $4.10 per ADS for gross proceeds of $2,500,000. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $7 Million Public Offering

evoke pharma logo

Press Release – New York, NY – February 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Discusses Delay of Fiduciary Rule on CNBC

Press Release – New York, NY– February 10, 2017 – Founding partner Gregory Sichenzia discussed the Trump administration’s potential rollback of the new fiduciary rule applicable to broker-dealers that was to go into effect in April 2018.  Greg noted that this new standard is likely to lead to substantial regulatory costs and may not result in better products or targeted advice.

 To view the video, click here.

Sichenzia Ross Ference Kesner LLP Partner Henry Nisser Interviewed by FinOps Report About Improper Handling of ADRs

Press Release – New York, NY – February 1, 2017 – Sichenzia Ross Ference Kesner LLP partner Henry Nisser was interviewed by the FinOps Report in its article titled “Pre-Release ADRs: More SEC Fines on the Way?” The article discusses ITG Inc.’s recent agreement to pay more than $24.4 million to settle charges that it violated federal securities laws when it prompted the issuance of American Depository Receipts (ADRs) without possessing the underlying foreign shares.  continue reading >>

Litigation Assistant

Sichenzia Ross Ference Kesner LLP is seeking a litigation assistant with 1-3 years of experience.

Job responsibilities include, but are not limited to:

  • Input billable hours of set name partners daily
  • Track and maintain retention chart of insurance cases and follow up with unpaid third-party invoices
  • Properly file and keep track of third-party document production of executed subpoenas and orders of production for cases
  • Manage deadlines on litigation calendar for department
  • Draft SEC and FINRA responses, bates stamp and properly file document productions
  • Prepare travel arrangements, manage personal calendars and screen phone calls for name partners
  • Assist in the preparation of mediations, depositions and hearings for litigation partners and associates
  • Experience in drafting table of contents and table of authorities required.
  • Experience in E-filing and using Pacer is preferred, but not required.

Please send resumes to mzavala@srfkllp.com

Senior Lawyer

Sichenzia Ross Ference Kesner LLP is seeking a senior lawyer or practice group with a portable business of at least $500,000 in the following disciplines: Mergers & Acquisitions, Commercial Real Estate Corporate/Transactional Tax, Executive Employment and Bankruptcy. Partnership potential. High pay outs. Great work environment and opportunity to cross-sell your practice with our existing core business of public company and investment banking clients.

Please contact mzavala@srfkllp.com

Sichenzia Ross Ference Kesner LLP Appoints Avital Even-Shoshan as Partner

Press Release – New York, NY– January 17, 2017 – The law firm of Sichenzia Ross Ference Kesner LLP today announced the promotion of Avital Even-Shoshan to partner.

“I am proud to congratulate Avital on this well-deserved promotion, which reflects her notable commitment to legal excellence and client service,” said founding partner Gregory Sichenzia. continue reading >>

Sichenzia Ross Ference Kesner LLP Appoints Morgan Weber as Counsel

New York, NY – January 17, 2017 – The law firm of Sichenzia Ross Ference Kesner LLP today announced the promotion of Morgan Weber to counsel.   

Morgan Weber, with over ten years of experience, is versed in complex litigation, in state and federal courts as well as before arbitration tribunals and regulatory agencies. She has substantial experience in litigation motion practice, discovery and trial preparation and appellate work in subjects relating to complex contracts, business litigation, intellectual property matters and real estate matters.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vycor Medical Inc. in an Internet Portal-based Private Placement

vycor medical inc.

Press Release – New York, NY – January 13, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Vycor Medical Inc. (OTCQB:VYCO) in a private placement with the Company’s existing accredited investor shareholders that was conducted  through an internet portal through which the Company provided potential investors with the offering  documents and accepted subscriptions.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Marc J. Ross Discusses Employment Issues Surrounding Marijuana Use

Press Release – New York, NY – December 18, 2016 – Sichenzia Ross Ference Kesner LLP Founding Partner Marc J. Ross was recently quoted in The Atlantic, a CityLab article titled “Don’t Bet Your Job on Legal Pot.” The article notes that because marijuana remains illegal under federal law, employers are still able to fire employees for using marijuana, whether medical or recreational, even when such use is permissible under state law.

continue reading >>

Sichenzia Ross Ference Kesner LLP Adds Noted Intellectual Property Lawyer Scott H. Kaliko to Head the Firm’s New IP Group

Press Release — New York, NY — December 19, 2016 — Sichenzia Ross Ference Kesner LLP (“SRFK”), highly respected for their work in the securities and capital markets industries, continued its expansion and diversification for the firm’s practice today and announced the addition of noted intellectual property lawyer Scott H. Kaliko as Counsel to the firm to head the firm’s new intellectual property group. Kaliko joins SRFK from his own firm, Kaliko & Associates, LLC of thirteen years, prior to which he held roles at JP Morgan Chase & Co., and Fish & Neave, LLP (now Ropes & Gray, LLP).

continue reading >>

Sichenzia Ross Ference Kesner Partner Harvey Kesner Quoted on DTC Rule Changes

Press Release – New York, NY – December 15, 2016 – Sichenzia Ross Ference Kesner LLP partner Harvey Kesner was quoted by the FinOps Report in an update to its article titled “Transfer Agents, DTC Still Chilly On Issuer Freeze Policies.” The article discusses the Depository Trust Company’s (DTC) rule changes which specify four circumstances under which the DTC can “chill” or “lock” issuers out of its services. The SEC is responsible for approving any rule changes made by the DTC, the US national depository, and approved the new rules on December 6, 2016.
continue reading >>

Sichenzia Ross Ference Kesner LLP Attorneys Harvey Kesner, Michael Ference, Sameer Rastogi, and Mendy Piekarski Prevail in Removing a Shareholder Derivative Lawsuit to Federal Court

Press Release – New York, NY – December 14, 2016 – Sichenzia Ross Ference Kesner LLP today announced that attorneys Harvey Kesner, Michael Ference, Sameer Rastogi and Mendy Piekarski prevailed in removing a shareholder derivative lawsuit to federal court.

continue reading >>

Founding Partner Marc J. Ross, Esq. Quoted on Impact of Trump AG Pick on Legal Cannabis Industry

Press Release – New York, NY – December 9, 2016 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq. was recently quoted in a Boston Globe article titled “Trump AG pick could halt legal pot industry,” where he commented on the future of the Marijuana Industry.  The article discusses how Senator Jeff Sessions, Donald Trump’s nominee for attorney general, who many think has a long history of opposition to marijuana, could impact the marijuana industry across the United States.  In particular, Sessions could choose to remove the Cole Memorandum, effectively repealing the protections that exist for marijuana and marijuana-related businesses in the states where marijuana is legal.  
continue reading >>

Founding Partner Marc J. Ross Quoted in Forbes Article on Marijuana Entrepreneurs Who Want Donald Trump to See Them as Job Creators

Press Release – New York, NY – December 6 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq. was recently quoted in a Forbes article titled “Marijuana Industry Entrepreneurs Want Donald Trump To See Them As Job Creators.” The article discusses that even though Donald Trump’s selection of anti-drug hardliner Alabama Senator Jeff Sessions for his attorney general nominee has entrepreneurs in the legal marijuana industry worried, there is hope that the cannabis sector’s positive impact on job creation and tax revenues will influence Donald Trump to maintain the existing legal protections for marijuana businesses.  

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. in $3.6 Million PIPE for Ener-Core, Inc.

ener-core

Press Release – New York, NY – December 5, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as Sole Placement Agent in private placement of $3.6 Million principal amount of convertible senior secured notes and warrants of Ener-Core, Inc.  (OTCQB. “ENCR”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $14.5 Million Registered Direct Offering.

vuzix view the future logo

Press Release – New York, NY – December 2, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2 million registered shares of its common stock at a price of $7.25 per share for gross proceeds to Vuzix of $14,500,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering. The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, Marcelle Balcombe and Counsel Jeff Cahlon.

Founding Partner Marc J. Ross Quoted on Inc.com on First Marijuana-Related Listing on the NYSE

Press Release – New York, NY – December 6, 2016 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq was quoted in an Inc.com article titled “NYSE Lists First Cannabis-Related Company.” The article discusses the IPO and NYSE listing of Innovative Industrial Properties, Inc., which will conduct business as an umbrella partnership real estate investment trust. The company focuses on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. and Feltl and Company in $13.5 Million PIPE for Midwest Energy Emissions Corp.

midwest energy

Press Release – New York, NY – November 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as lead Placement Agent and Feltl and Company as Co-Placement Agent in a private placement offering of Common Stock ofMidwest Energy Emissions Corp. ME2C (OTCQB. “MEEC”). continue reading >>

Ten SRFK LLP Attorneys Named Super Lawyers & Rising Stars

Press Release — New York, NY — November 4, 2016  — Sichenzia Ross Ference Kesner LLP is pleased to announce that four partners have once again been named 2016 Super Lawyers. Additionally six other attorneys have been named 2016 Rising Stars.

Super Lawyers, a Thomson Reuters business, is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high degree of peer recognition and professional achievement. Each year, no more than five percent of the lawyers in New York  are selected by the research team at Super Lawyers to receive this honor.

The attorneys who have been selected for the 2016 honors are:  continue reading >>

Sichenzia Ross Ference Kesner LLP Selected to ‘Best Law Firms’ by US News and World Report

Press Release — New York, NY — November 3, 2016 – Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has been selected in the 7th Edition of Best Law Firms by US News & World Report for 2017 under the category of Corporate Law.  In addition, Founding Partner, Gregory Sichenzia has also been listed in Best Lawyers under the category of Corporate Law since 2016.

Sichenzia Ross Ference Kesner LLP Congratulates TapImmune Inc. on NASDAQ Uplisting

New York, NY – November 3, 2016 – Sichenzia Ross Ference Kesner LLP announced today that the Firm has represented TapImmune Inc. (NASDAQ: TPIV), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross  Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Associate Jay Yamamoto. The uplisting is effective for trading on November 8, 2016 and TapImmune’s common stock will trade under its existing stock symbol “TPIV.”

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, Feltl and Company and Fordham Financial Management in $8.6 Million Public Offering of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co. and Feltl and Company as Joint Book -Running Managers and Fordham Financial Management, Inc. as Lead Manager in a firm commitment underwritten public offering of equity securities of Aytu BioScience, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals in $5.2 Million Public Offering

tonix pharmaceuticals

Press Release – New York, NY – November 1, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Tonix Pharmaceuticals Holding Corp. (NASDAQ “TNXP”), a developer of next-generation medicines for common disorders of the central nervous system, continue reading >>

Sichenzia Ross Ference Kesner LLP Represents ToughBuilt Industries, Inc. in $6.1 Million Private Offering

toughbuilt logo

Press Release – New York, NY – October 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented ToughBuilt Industries, Inc. (“ToughBuilt”) in a private placement of equity as well as debt securities.  ToughBuilt is a private company that markets and distributes various home improvement and construction product lines for both do-it-yourself and professional markets under the TOUGHBUILT® brand name within the global multi-billion dollar per year tool market industry.

continue reading >>

Sichenzia Ross Ference Kesner LLP Announces Change of Name

New York, New York October 17, 2016 — Sichenzia Ross Ference Kesner LLP, a leading securities and corporate law firm, is pleased to announce that Harvey Kesner has joined Gregory Sichenzia, Marc Ross and Michael Ference in renaming the firm “SRFK LLP.”  The newly renamed law firm represents the continuation of the firm’s 18 year commitment to excellence through serving the needs of public and private companies, their financiers and the broker-dealer and financial services community. The firm, previously named Sichenzia Ross Friedman Ference LLP and founded by Gregory Sichenzia, Marc Ross and Michael Ference 18 years ago, first welcomed Harvey Kesner as a partner in 2009.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents ABT Holdings, Inc. in $5 Million Private Offering of Senior Secured Convertible Debentures

abt logo

October 17, 2016 — New York, NY — Sichenzia Ross Ference Kesner LLP has represented ABT Holdings, Inc. (OTC.PK: ABOT), a diversified holding company engaged in investing, acquiring, developing, and growing various businesses, in a private offering of $5 Million of Senior Secured Convertible Debentures. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $3 Million Private Placement

fte networks logo

Press Release – New York, NY – October 17, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of FTE Networks, Inc. (OTCQX: FTNW), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Network 1 Securities in $7.7 Million IPO and NASDAQ listing of ShineCo, Inc.

shineco inc

Press Release – New York, NY – September 30, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it represented Network 1 Financial Securities, Inc. as underwriter in a $7.7 million best efforts Initial Public Offering of 1,713,190 shares of common stock of ShineCo, Inc. (Nasdaq TYHT) at a public offering price of $4.50 per share. Monarch Bay Securities participated as a selected dealer. Shineco is a producer and distributor of Chinese herbal medicines, organic agricultural produce and other health based plant products in China. The Sichenzia Ross Friedman Ference LLP team was led by Partners Marc Ross and Henry Nisser.

continue reading >>

Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering

biopharmx

Press Release – New York, NY – September 29, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented BioPharmX Corporation (NYSE. MKT “ BPMX) in a Registered Direct public offering of 1,550,000 registered shares of its common stock at a price of $.60 per share and 1,240,000 unregistered warrants to purchase common stock at an exercise price of $.75 per share for gross proceeds to BPMX of $930,000. Rodman & Renshaw a Unit of H.C. Wainwright & Co., LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe and Counsel Jeff Cahlon.

continue reading >>

Partner Harvey Kesner Represents Towerstream Corporation in $4 Million Public Offering

towerstream

Press Release – New York, NY – September 26, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented Towerstream Corporation (NASDAQ: TWER) in a firm commitment underwritten public offering of 2,962,963 shares of its common stock at a public offering price of $1.35 per share, for gross proceeds to Towerstream of $4,000,000. Laidlaw & Company (UK) Ltd. acted as the sole book running managing underwriter for the offering.

The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner, Avital Even-Shoshan and Evan Berger.

continue reading >>

Sichenzia Ross Friedman Ference LLP and its Israeli Affiliate DTKGC-SRFF Represent an Investment Group in Buy Out of ThermaSteel, Inc.

September 23, 2016 — New York, NY and Tel Aviv. Sichenzia Ross Friedman Ference LLP (“SRFF”) and Its Israeli Affiliate Doron Tikotzky Kantor Gutman Cederbaum-SRFF (“DTKGC-SRFF”) have represented an Israeli investment group led by Mr. Adi Ben-Senior in the acquisition of ThermaSteel, Inc. of Radford Virginia in a multi-million dollar transaction ThermaSteel has developed a patented bonding technology that bonds light gauge steel to EPS, creating composite structural wall panel system. www.thermsteelinc.com. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents General Cannabis Corp. in $2.6 million Private Offering of Senior Secured Notes and Warrants

general cannabis

September 22, 2016 — New York, NY –  Sichenzia Ross Friedman Ference LLP (“SRFF”)  has represented General Cannabis Corp. (OTCQB: CANN), a leading cannabis industry company, focused on being the all-in-one resource for quality service providers in the regulated cannabis industry, in a private offering of $2.6 million of Senior Secured Promissory Notes and Common Stock Purchase Warrants.

The Sichenzia Ross Friedman Ference LLP team was led by Partners Arthur Marcus and Gregory Sichenzia. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents SITO MOBILE, Ltd. in $11.5 Million Public Offering

sito - single touch interactive

Press Release – New York, NY – September 21, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented SITO Mobile, Ltd. (NASDAQ “SITO”) in a firm commitment underwritten public offering of 3,066,667 shares of its common stock, including exercise of the underwriter’s overallotment option, at a public offering price of $3.75 per share, for gross proceeds to SITO of $11,500,000. Cowen & Co. Inc. acted as the sole book running managing underwriter for the offering. The offering was led by several institutional investors.  The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Counsel Jeff Cahlon and Associate S. Ashley Jaber.

continue reading >>

Sichenzia Ross Friedman Ference LLP is the Marquee Sponsor of the Aegis Capital Corp. 2016 Growth Conference in Las Vegas, Nevada

Press Release – New York, NY – September 16, 2016 – Sichenzia Ross Friedman Ference LLP is the Marquee Sponsor of the 2016 Aegis Growth Conference to be held at The Encore at Wynn Las Vegas September 20 through September 22, 2016.  A memorable and exciting conference is anticipated with numerous public companies presenting their businesses to a large audience of attendees.

On September 22, 2016, founding partner, Michael H. Ference will be moderating a panel focusing on Small Cap Financing. The panel will be comprised of experts in the field including: continue reading >>

Sichenzia Ross Friedman Ference LLP Attorneys Achieve Complete Dismissal of Lawsuit

Press Release – September 13, 2016 – New York, NY – Sichenzia Ross Friedman Ference attorneys Mendy Piekarski and Marc Ross achieve a complete dismissal of a lawsuit seeking unwarranted finder’s fees and commissions. Plaintiff sought fees for purportedly making introductions that resulted in certain corporate acquisitions and financings.

continue reading >>

Partner Gregory Sichenzia Writes “Today’s Tech-Savvy Kids Are Tomorrow’s Investors” for Huffington Post

New York, NY – September 7, 2016 – Partner Greg Sichenzia wrote an article for Huffington Post Business titled “Today’s Tech-Savvy Kids are Tomorrow’s Investors.” The article provides an overview of future projected investment behavior of Millennials, Generation Z and Generation Alpha, and provides tips on market segments that might appeal to these generations. 

Read the full article here

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering

cel sci

Press Release – New York, NY – August 26, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as the exclusive placement agent for a registered direct offering of CEL-SCI Corporation (NYSE MKT: CVM), a pharmaceutical company that is focused on finding the best way to activate a patient’s immune response to fight cancer and infectious diseases (“CEL-SCI”).

continue reading >>

Partner Harvey Kesner Represents Rant, Inc. in its Acquisition by Function(X), Inc. and RACX Inc.

rant logo

New York, NY – August 29, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rant, Inc. (“Rant”) in its acquisition by Function(X), Inc. (“Fn(X)”) and its wholly-owned subsidiary, RACX Inc. (“RACX”).  RACX acquired Rant’s assets used in the operation of Rant’s Rant.com independent media network and related businesses.

continue reading >>

Partner Harvey Kesner Represents MabVax Therapeutics Holdings, Inc. on NASDAQ Uplisting and $9.4 Million Public Offering

mabvax therapeutics

New York, NY – August 29, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage oncology drug development company, on its successful uplisting to The Nasdaq Capital Market and a public offering of common stock and Series F Preferred Stock and warrants for a total of $9.4 million, including approximately $800,000 received from the underwriter in exercising the full amount of its over-allotment option.

continue reading >>

Sichenzia Ross Friedman Ference LLP Congratulates Biomerica, Inc. on NASDAQ Uplisting

New York, NY – August 25, 2016 –   Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Biomerica, Inc.  (NASDAQ: BMRA), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Friedman Ference LLP team was led by founding Partner Gregory Sichenzia and Associate Jay Yamamoto. The uplisting is effective for trading on August 26, 2016 and Biomerica’s common stock will trade under its existing stock symbol “BMRA.”

continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Aridis Pharmaceuticals in $15 Million Private Placement

aridis

PRESS RELEASE – New York, NY – August 25, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, in a private placement of preferred stock and warrants resulting in total gross proceeds of $15,216,241.  continue reading >>

SRFF Represents Medovex Corp. In $1.3 Million Private Placement

medovex corporation

Press Release – New York, NY – August 23, 2016 – Securities and Corporate law firm Sichenzia Ross Friedman Ference is pleased to announce that the firm has represented Medovex Corp. (NASDAQ-MDVX), a medical products manufacturer in a private placement of units consisting of 1,083,333 shares of common stock and 541,667 warrants to purchase common stock at a fixed price of $1.20 per unit without a placement agent resulting in gross proceeds of $1,560,000. continue reading >>

OktoberINVESTfest in NY, NY on September 28, 2016

oktoberinvestfest

Sichenzia Ross Friedman Ference LLP is a sponsor of the 5th Annual OktoberINVESTfest Conference to be held at the New York Academy of Science on September 28, 2016.  The OktoberINVESTfest aims to foster innovation and transatlantic investment by enabling investors to learn about selected high quality American and German unique investment opportunities, both public and private, in the life science and IT sectors. This high energy event is hosted by Invest in Bavaria, the investment promotion agency of Germany’s largest, most innovative state, Bavaria, whose capital is Munich.

The 2016 program will feature distinguished panelists and speakers complimented by networking at the Unconference Luncheon. Throughout the day some 40 U.S. and German top investment opportunities will present their innovations and businesses. The conference portion of the event will close with a presentation of Bavarian Innovations. The final highlight of the event will be the Little Oktoberfest, where partners and participants will solidify their new relationships over Bavarian beer and cuisine.

September 28, 2016
New York City
8:00AM – 6:00PM

New York Academy of Science
7 World Trade Center, 40th Fl., NYC

Visit here (http://www.oktoberinvestfest.com/) to learn more.

Sichenzia Ross Friedman Ference LLP Ranked #2 in PrivateRaise’s Q2 2016 PIPE League Tables

Press Release – New York, NY – July 15, 2016 – Sichenzia Ross Friedman Ference LLP was ranked #2 issuer counsel in PrivateRaise’s Q2 PIPE league tables by the number of placements advised. The Firm was also ranked #6 placement agent counsel.  PrivateRaise, a service of The Deal, ranks the top investment managers, placement agents, placement agent legal counsel, issuer legal counsel, and investor legal counsel by the total number of placements advised each quarter.

continue reading >>

Rodman & Renshaw Conference in NY, NY on September 11-13, 2016

Sichenzia Ross Friedman Ference LLP is a silver sponsor of the 18th Annual Rodman & Renshaw Global Investment Conference to be held at the Palace Hotel in New York City on September 11 to September 13.  A memorable and exciting conference is anticipated with approximately 200 public and private companies presenting their businesses to an audience of approximately 2,000 attendees. The conference will focus on tracks dedicated to healthcare, natural resources, cleantech, and technology, media and telecommunications. Keynote speakers will include the Rt Hon Sir John Major KG CH, Former Prime Minister of Great Britain and Northern Ireland, and Jeb Bush, the 43rd governor of Florida.

September 11 – 13, 2016
New York City
Lotte New York Palace Hotel
455 Madison Avenue at 50th Street
New York, NY 10022

Visit here to learn more.

Sichenzia Ross Friedman Ference LLP Attorneys To Join Client DelMar Pharmaceuticals, Inc. at Nasdaq Opening Bell Ringing

Press Release – New York, NY – July 14, 2016 – Sichenzia Ross Friedman Ference LLP partners Gregory Sichenzia and David Manno and counsel Jeffrey Cahlon will join representatives of client DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a clinical stage drug development company with a focus on the treatment of cancer, at the Nasdaq MarketSite in Times Square to ring the July 14 opening bell.
continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $3.77 Registered Direct Offering

eyegate pharma logo

Press Release – New York, NY – July 11, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as the exclusive placement agent for a registered direct offering of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye (“EyeGate”).

continue reading >>

Partner Harvey Kesner Represents Towerstream Corporation on $1.25 Private Placement

towerstream

Press Release – New York, NY – July 11, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Towerstream Corporation (NASDAQ: TWER), a leading fixed-wireless fiber alternative company, on a private placement of 892,857 shares of Series B Preferred Stock and five year warrants to purchase  223,214 shares of common stock.  Each preferred share is convertible into 0.5 shares of common stock and the warrants have an exercise price of $3.00.  
continue reading >>

Partner Harvey Kesner Represents Towerstream Corporation on $2.28 Million Registered Direct Offering

towerstream

Press Release – New York, NY – July 1, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Towerstream Corporation (NASDAQ: TWER), a leading fixed-wireless fiber alternative company, on a registered direct offering of 15,000,000 shares of the Company’s common stock at a public offering price per share of $0.152 per share without an underwriter or placement agent.  Each purchaser also received a five year warrant exercisable at $0.25 per share for each share of common stock purchased.

continue reading >>

Partner Harvey Kesner Represents Chromadex Corporation on $5.25 Million Registered Direct Offering

chromadex logo

Press Release – New York, NY – July 1, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Chromadex Corporation (NASDAQ: CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, on a registered direct offering of 1,117,022 shares of the Company’s common stock at a public offering price per share of $4.70 without an underwriter or placement agent.

continue reading >>

Sichenzia Ross Friedman Ference LLP Appoints Jeff Cahlon Counsel

New York, NY – (June 30, 2016) – Sichenzia Ross Friedman Ference LLP, the nationally ranked leading securities and corporate law firm, is pleased to announce today that it has promoted Jeffrey Cahlon to counsel from associate.

Mr. Cahlon joined the firm in 2007. His practice focuses on representing issuers, underwriters and investors in corporate financing transactions, including public and private equity and debt securities offerings, mergers and acquisitions, Exchange Act and Securities Act reporting and compliance, and general corporate and securities law.

“We are pleased to promote Jeff,” said founding partner Gregory Sichenzia. “Over the past nine years with us he has consistently demonstrated legal excellence and shown himself as an expert in a specialized and complex space.”

Mr. Cahlon’s full biography is available here:  http://srfkllp.com/jeffrey-cahlon/

Partner Harvey Kesner Worked with Other Counsel to Successfully Petition for Removal of Defamatory Web Postings

Press Release – New York, NY – July 1, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that partner Harvey Kesner and associate Cass Sanford, together with other counsel, successfully petitioned for removal of defamatory web postings from Google and Ripoff Report. continue reading >>

Partners Marc J. Ross and James M. Turner Represent Tonix Pharmaceuticals in $10 Million Public Offering of Common Stock

tonix pharmaceuticals

Press Release – New York, NY – June 23, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a developer of next-generation medicines for common disorders of the central nervous system, continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc.

intellicheck logo

Press Release – New York, NY – June 21, 2016 – Nationally recognized securities and corporate law firm, Sichenzia Ross Friedman Ference LLP, announced today that it has represented Joseph Gunnar & Co. LLC as sole book-running manager in a firm commitment underwritten public offering of shares and warrants of Intellicheck Mobilisa, Inc.

continue reading >>

Partner Gregory Sichenzia Quoted in Los Angeles Times article on Uber’s Entry into Leveraged Loan Market

New York, NY – June 16, 2016 – Partner Greg Sichenzia was quoted in a Los Angeles Times article titled “Uber reportedly seeks to raise up to $2 billion in the leveraged loan market”.  The article discusses Uber’s engagement of Morgan Stanley and Barclays to sell a leveraged loan of $1 billion to $2 billion to institutional investors. Leveraged loans are similar to junk bonds in that they are deemed high risk, but return higher yields.  Greg shared his views on the expected interest rates of the leveraged loans.

Read the full article here. 

Partner Gregory Sichenzia Writes “3 Fundraising Options to Consider During a Tepid IPO Market” for Huffington Post

June 13, 2016 – Partner Greg Sichenzia wrote an article for Huffington Post Business titled “3 Fund Raising Options to Consider During a Tepid IPO Market.” The article describes three types of financing activities private companies that want to raise funds to list on a national exchange can consider as an alternative to the traditional underwritten IPO: private investments in public equity, or PIPEs, reverse mergers, and partnerships with existing corporations.

Read the full article here. 

 

Partner Gregory Sichenzia Quoted in a Los Angeles Times article on Microsoft’s Purchase of LinkedIn

New York, NY – June 13, 2016 – Partner Greg Sichenzia was quoted in a Los Angeles Times article titled “Microsoft to buy networking site LinkedIn for $26.2 billion.”  The article discussed Microsoft Corp.’s announcement today that it would acquire LinkedIn in a $26.2 billion all cash transaction that is expected to close this year.  Greg said that the acquisition is a “big and bold step” for Microsoft and a “great deal for LinkedIn,” making Microsoft a more socially relevant company and providing LinkedIn with new capital to grow.

Read the full article here.

 

1 2 3 8